[HTML][HTML] Emerging role of immune checkpoint blockade in pancreatic cancer
Immune checkpoint blockade (ICB) with programmed cell death protein-1 (PD-
1)/programmed death ligand-1 (PD-L1) antibodies has revolutionized the management of …
1)/programmed death ligand-1 (PD-L1) antibodies has revolutionized the management of …
[HTML][HTML] Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: evidence from an FDA pooled analysis of landmark clinical …
Purpose The development of treatment-related adverse events (trAE) correlates favorably
with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors …
with clinical outcomes in multiple studies of patients receiving immune checkpoint inhibitors …
[HTML][HTML] Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: adjunctive role of the ALBI grade
Immune checkpoint inhibitors (ICI) have shown positive results in patients with
hepatocellular carcinoma (HCC). As liver function contributes to prognosis, its precise …
hepatocellular carcinoma (HCC). As liver function contributes to prognosis, its precise …
Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma
Abstract Background and Rationale: Immune checkpoint inhibitor (ICI) therapy is an
expanding therapeutic option for hepatocellular carcinoma (HCC). Antibiotics (ATB) taken …
expanding therapeutic option for hepatocellular carcinoma (HCC). Antibiotics (ATB) taken …
[HTML][HTML] Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
P Fessas, A Kaseb, Y Wang, A Saeed… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Original research: Post-registration experience of nivolumab in advanced hepatocellular
carcinoma: an international study - PMC Back to Top Skip to main content NIH NLM Logo …
carcinoma: an international study - PMC Back to Top Skip to main content NIH NLM Logo …
[HTML][HTML] Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
The impact of corticosteroid therapy (CT) on efficacy of immune checkpoint inhibitors (ICI) is
undefined in hepatocellular carcinoma (HCC). We evaluated whether CT administered at …
undefined in hepatocellular carcinoma (HCC). We evaluated whether CT administered at …
[PDF][PDF] Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
The availability of immune checkpoint inhibitors (ICIs) for the management of advanced
hepatocellular cancer (HCC) has changed the treatment paradigm. There are emerging …
hepatocellular cancer (HCC) has changed the treatment paradigm. There are emerging …
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer
Background Besides modeling/simulation-based analysis, no post-approval studies have
evaluated the optimal administration frequency of pembrolizumab in non–small-cell lung …
evaluated the optimal administration frequency of pembrolizumab in non–small-cell lung …
[HTML][HTML] Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literature
J Vera-Aguilera, O Mukarram, P Nutalapati… - Journal of Medical Case …, 2016 - Springer
Background Acute myeloid leukemia is typically a disease of the older population and
presents mostly in the fifth decade of life. Myeloid sarcoma is a rare initial presentation of …
presents mostly in the fifth decade of life. Myeloid sarcoma is a rare initial presentation of …
The real-world incidence of immunotherapy-related thyroid dysfunction: A retrospective analysis of a single center's experience over five years.
HM Brody, S Macherla, A Bulumulle, P Namireddy… - 2020 - ascopubs.org
98 Background: Immunotherapy related thyroid abnormalities are well described. Any grade
abnormality has been reported in 6-18% of patients. The clinical relevance of thyroid …
abnormality has been reported in 6-18% of patients. The clinical relevance of thyroid …